These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20122172)

  • 1. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.
    Koskimaki JE; Karagiannis ED; Tang BC; Hammers H; Watkins DN; Pili R; Popel AS
    BMC Cancer; 2010 Feb; 10():29. PubMed ID: 20122172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.
    Koskimaki JE; Karagiannis ED; Rosca EV; Vesuna F; Winnard PT; Raman V; Bhujwalla ZM; Popel AS
    Neoplasia; 2009 Dec; 11(12):1285-91. PubMed ID: 20019836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IV.
    Weckmann M; Moir LM; Heckman CA; Black JL; Oliver BG; Burgess JK
    J Cell Mol Med; 2012 Dec; 16(12):3062-73. PubMed ID: 22998238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular basement membrane-derived multifunctional peptide, a novel inhibitor of angiogenesis and tumor growth.
    Cao JG; Peng SP; Sun L; Li H; Wang L; Deng HW
    Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):514-21. PubMed ID: 16820868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
    Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
    Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA; Luo JX; Zhang TY; Wang FY; Li RF
    Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
    Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
    Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of recombinant anti-angiogenic peptide of tumstatin on growth and metastasis of human ovarian cancer transplanted in nude mice].
    Zhang GM; Sui LH; Jia T; Zhao YZ; Fu SB; Liu XH; Yu Y
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):170-3. PubMed ID: 18756929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivo.
    He Y; Jiang Y; Li YJ; Liu XH; Zhang L; Liu LJ; Shi H; Li HN; Ma YC; Jin XM
    J Gastroenterol Hepatol; 2010 May; 25(5):935-41. PubMed ID: 20546447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
    Yi ZF; Cho SG; Zhao H; Wu YY; Luo J; Li D; Yi T; Xu X; Wu Z; Liu M
    Int J Cancer; 2009 Feb; 124(4):843-52. PubMed ID: 19035465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice.
    Miyoshi T; Hirohata S; Ogawa H; Doi M; Obika M; Yonezawa T; Sado Y; Kusachi S; Kyo S; Kondo S; Shiratori Y; Hudson BG; Ninomiya Y
    FASEB J; 2006 Sep; 20(11):1904-6. PubMed ID: 16877525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.
    Karagiannis ED; Popel AS
    Biochem Biophys Res Commun; 2007 Mar; 354(2):434-9. PubMed ID: 17239819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
    Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
    Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
    Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
    Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth.
    Rosca EV; Lal B; Koskimaki JE; Popel AS; Laterra J
    Anticancer Drugs; 2012 Aug; 23(7):706-12. PubMed ID: 22495619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel peptide-specific quantitative structure-activity relationship (QSAR) analysis applied to collagen IV peptides with antiangiogenic activity.
    Rivera CG; Rosca EV; Pandey NB; Koskimaki JE; Bader JS; Popel AS
    J Med Chem; 2011 Oct; 54(19):6492-500. PubMed ID: 21866962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.